PHASEI/II

Clinical trials for PHASEI/II explained in plain language.

Never miss a new study

Get alerted when new PHASEI/II trials appear

Sign up with your email to follow new studies for PHASEI/II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo targets Tough-to-Treat lymphoma

Disease control Not yet recruiting

This early-stage study is testing a new drug called EMB-07, given in combination with other therapies, for adults with aggressive B-cell non-Hodgkin lymphoma. The main goals are to find a safe dose and see if the treatment can shrink tumors. It will enroll about 115 people, inclu…

Matched conditions: PHASEI/II

Phase: PHASE1, PHASE2 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control

Last updated Apr 02, 2026 01:12 UTC

PHASEI/II

Get alerted when new PHASEI/II trials appear

New drug combo targets Tough-to-Treat lymphoma